Only four subgroups (AFP ≥ 400 ng/mL, ALT < 41 IU/L, PT < 12 s, and macrovascular invasion positive) of HCC were significantly associated with shorter intrahepatic recurrence-free survival (Figure 3). The gene discussed is GPT; the disease is hepatocellular carcinoma.